ESM Technologies Receives Patent Allowance

CARTHAGE, MOESM Technologies received a Notice of Allowance from the U.S. Patent and Trademark Office for its application called, "Anti-inflammatory Activity of Eggshell Membrane and Processed Eggshell Membrane Preparations."

"This allowance will build upon the patent support of our flagship eggshell membrane ingredient and the intellectual property behind processing the unique ingredient and its novel uses," said Kevin J. Ruff, Ph.D, director of scientific and regulatory affairs, ESM Technologies.

ESM holds multiple patents relating to eggshell membrane separation technology and uses for the resulting separated membrane. This most recent patent application builds upon the company's prior uses for eggshell membrane by expanding coverage for not only eggshell membrane alone, but also hydrolysates and/or isolates of eggshell membrane combinations for the reduction of pro-inflammatory cytokines in various inflammatory conditions such as arthritis.

According to Journal of Medical Food eggshell membrane has been shown in vitro to reduce the production of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) by human immune cells when stimulated. The allowance of this patent application positions eggshell membrane as a natural composition for supporting a healthy inflammatory response.

Explore the benefits of eggshell membrane for athletes in the INSIDER article, "Sports Ingredients Keep 'em Moving."